ClinOps · Ostroff AI
Vascular Access Overwatch

Detect risk.
Guide action.
Connect expertise.

Augmented reality decision support for vascular access teams — from PICC nurses to interventional radiology.

Decision support that strengthens — not replaces — clinical judgment.

The Problem

Vascular access shouldn’t be guesswork.

1 in 5 first attempts fail. Complications — arterial injury, pneumothorax, CLABSI — can add $46K or more per event.

Clinician performing vascular access
Current Practice
EMR
Lab results
Imaging
Ultrasound

Essential information stays scattered across systems — while the decision happens at the bedside, in seconds.

Sources: Angles et al. 2021, J Clin Anesth (20.3% first-attempt failure, n=3,367) · Zimlichman et al. 2013, JAMA Intern Med (~$46K added cost per CLABSI). Full citations available on request.

The Safety Bridge
Augmented reality · point of care · safety & decision support

Meet Ostroff AI.

See risk. Avoid harm. Choose the safer path.

Designed by globally renowned vascular access expert Matthew Ostroff and a global team of vascular access advisors.

Matthew Ostroff, MSN, APRN
Matthew Ostroff, MSN, APRN
Founder, Virtual Institute for Vascular Access (VIVA)
Risk Watch
Path Watch
Expert Watch

Connected intelligence at the point of care — delivered through augmented reality, at the bedside.

Clinician using Ostroff AI augmented reality glasses
Point-of-Care Transformation

Ostroff AI turns data into safer action.

One intelligent view — delivered through augmented reality at the bedside.

01
Detect
EMR, diagnostics and live ultrasound surface patient-specific risk.
02
Guide
Safer site, pathway and procedure choices, mapped to the patient.
03
Connect
Remote expertise, on demand, within the clinician’s view.
From fragmented data to informed decisions

Detect risk. Guide action. Connect expertise.

Ostroff AI — decision support built for the point of care. Let’s scope a pilot with your vascular access team.

Start a pilot conversation

Decision support — not a replacement for clinical judgment. Not yet cleared by FDA; shown for illustration only.